BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 4:56:00 PM | Browse: 1098 | Download: 1295
 |
Received |
|
2012-12-20 01:56 |
 |
Peer-Review Started |
|
2012-12-20 14:46 |
 |
To Make the First Decision |
|
2012-12-27 12:18 |
 |
Return for Revision |
|
2012-12-28 16:59 |
 |
Revised |
|
2013-01-09 23:51 |
 |
Second Decision |
|
2013-01-23 16:52 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-01-24 07:46 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-02-25 14:43 |
 |
Publish the Manuscript Online |
|
2013-03-01 15:37 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Case Report |
Article Title |
Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor
|
Manuscript Source |
Invited Manuscript |
All Author List |
Guan-Min Lai, Sheng-Lei Yan, Cheng-Shyong Chang and Chien-Yu Tsai |
Funding Agency and Grant Number |
|
Corresponding Author |
Cheng-Shyong Chang, MD, Division of Hemato-Oncology, Department of Internal Medicine, Changhua Christian Hospital, Changhua 500, Taiwan. 15120@cch.org.tw
|
Key Words |
Hepatitis B virus; Chronic myeloid leukemia; Imatinib mesylate; Nilotinib; Tyrosine kinase inhibitor |
Core Tip |
|
Publish Date |
2013-03-01 15:37 |
Citation |
Lai GM, Yan SL, Chang CS, Tsai CY. Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor. World J Gastroenterol 2013; 19(8): 1318-1321 |
URL |
http://www.wjgnet.com/1007-9327/full/v19/i8/1318.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v19.i8.1318 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345